It is important to underline that the hierarchical or CSC plasticity model does not address the PLC cell-of-origin, which represents the cell acquiring the first cancer-promoting mutation(s) and is not necessarily related to the CSC concept [9]. The gene discussed is HSPG2; the disease is cancer.